IFP Advisors, Inc - CYMABAY THERAPEUTICS INC ownership

CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 142 filers reported holding CYMABAY THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.69 and the average weighting 0.5%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of CYMABAY THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$9,692
-36.9%
650
-50.0%
0.00%
Q2 2023$15,359
+86.4%
1,300
+100.0%
0.00%
Q1 2023$8,242
+39147.6%
650
-60.6%
0.00%
-100.0%
Q4 2022$21
-99.9%
1,6500.0%0.00%0.0%
Q3 2022$21,0000.0%1,6500.0%0.00%0.0%
Q2 2022$21,000
-27.6%
1,650
-28.3%
0.00%
Q1 2022$29,000
+1350.0%
2,300
+253.8%
0.00%
Q4 2021$2,0000.0%6500.0%0.00%
Q3 2021$2,000
-33.3%
6500.0%0.00%
Q2 2021$3,0000.0%6500.0%0.00%
Q1 2021$3,000
-25.0%
6500.0%0.00%
Q4 2020$4,000
-20.0%
6500.0%0.00%
Q3 2020$5,0006500.00%
Q2 2020$000.00%
Q1 2020$000.00%
Q4 2019$000.00%
Q3 2019$0
-100.0%
0
-100.0%
0.00%
Q4 2018$8,000
-27.3%
1,0200.0%0.00%
Q3 2018$11,000
-15.4%
1,020
+2.0%
0.00%
-100.0%
Q2 2018$13,000
-71.7%
1,000
-80.0%
0.00%
-50.0%
Q1 2018$46,0000.0%5,0000.0%0.00%0.0%
Q4 2017$46,000
+15.0%
5,0000.0%0.00%0.0%
Q3 2017$40,000
+73.9%
5,000
+25.0%
0.00%
+100.0%
Q2 2017$23,0004,0000.00%
Other shareholders
CYMABAY THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 1,653,495$10,367,4148.97%
Versant Venture Management, LLC 543,753$3,409,3307.06%
TCG Crossover Management, LLC 5,905,400$37,026,8586.54%
COMMODORE CAPITAL LP 5,738,500$35,9805.42%
Foresite Capital Management IV, LLC 1,787,094$11,205,0794.79%
Saturn V Capital Management LP 1,611,778$5,718,4324.74%
ACUTA CAPITAL PARTNERS, LLC 1,015,000$6,364,0503.92%
Altium Capital Management LP 1,025,000$6,426,7503.27%
Affinity Asset Advisors, LLC 1,143,531$7,169,9392.81%
GREAT POINT PARTNERS LLC 1,550,000$9,718,5001.90%
View complete list of CYMABAY THERAPEUTICS INC shareholders